Inventor · disambiguated record
Ouathek Ouerfelli
Also filed as: OUERFELLI OUATHEK
25 granted patents·15 pending applications·263 citations·filing 1996–2024
95Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER15ARAGON PHARMACEUTICALS INC9SLOAN KETTERING INST CANCER7SLOAN-KETTERING INST FOR CANCER RES2DANISHEFSKY SAMUEL J1
Top patents by PatentIndex Score
40 records- 0196US8987452B2Synthesis of thiohydantoinsSLOAN KETTERING INST CANCER·Filed 2013·Granted Mar 24, 2015·16 cites·6 claims
- 0294US9512103B2Synthesis of thiohydantoinsSLOAN-KETTERING INST FOR CANCER RES·Filed 2015·Granted Dec 6, 2016·9 cites·10 claims
- 0393US8461343B2Synthesis of thiohydantoinsOUERFELLI OUATHEK·Filed 2008·Granted Jun 11, 2013·28 cites·17 claims
- 0493US7399461B2Prostate-specific membrane antigen and uses thereofSLOAN KETTERING INST CANCER·Filed 2003·Granted Jul 15, 2008·44 cites·1 claims
- 0589US6670348B1Methods and compositions for destruction of selected proteinsSLOAN KETTERING INST CANCER·Filed 1998·Granted Dec 30, 2003·85 cites·40 claims
- 0689US6569432B1Prostate-specific membrane antigen and uses thereofSLOAN KETTERING INST CANCER·Filed 1996·Granted May 27, 2003·60 cites·1 claims
- 0789US2025092011A1Crystalline Forms Of An Androgen Receptor ModulatorARAGON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0885US10934271B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2020·Granted Mar 2, 2021·1 cites·17 claims
- 0985US9481663B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 1, 2016·5 cites·21 claims
- 1084US10308630B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·2 cites·9 claims
- 1182US11673961B2Anti-CD20 antibody and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Jun 13, 2023·4 cites·20 claims
- 1278US11565005B2Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jan 31, 2023·1 cites·23 claims
- 1378US10766875B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·0 cites·19 claims
- 1477US12018008B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2021·Granted Jun 25, 2024·0 cites·41 claims
- 1577US9994545B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·1 cites·21 claims
- 1677US9242994B2Treatment of pancreatic and related cancers with 5-acyl-6,7-dihydrothieno[3,2-c]pyridinesSLOAN KETTERING INST CANCER·Filed 2013·Granted Jan 26, 2016·4 cites·13 claims
- 1775US9597320B2Treatment of pancreatic and related cancers with 5-acyl-6,7-Dihydrothieno[3,2-C]pyridinesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Mar 21, 2017·2 cites·20 claims
- 1875US2025345466A1Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1972US10556882B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2019·Granted Feb 11, 2020·0 cites·19 claims
- 2072US10526310B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2019·Granted Jan 7, 2020·0 cites·21 claims
- 2163US9303009B2Migrastatins and uses thereofDANISHEFSKY SAMUEL J·Filed 2012·Granted Apr 5, 2016·1 cites·25 claims
- 2263US2004001846A1Prostate-specific membrane antigen and uses thereofSLOAN KETTERING INST CANCER·Filed 2003·Application pending·0 cites
- 2362US9926291B2Synthesis of thiohydantoinsSLOAN KETTERING INST CANCER RES·Filed 2016·Granted Mar 27, 2018·0 cites·8 claims
- 2462US2025230124A1Small molecule inhibitors of id proteinsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 2558US2010310452A1Prostate-specific membrane antigen and uses thereofSLOAN KETTERING INST CANCER·Filed 2001·Application pending·0 cites
- 2655US2023165826A1Inhalational therapy for covid-19MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 2754US11413354B2N-acetylgalactosamino dendron-clearing agent for dota-pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Aug 16, 2022·0 cites·20 claims
- 2853US9943507B2Treatment of pancreatic and related cancers with 5-acyl-6,7-dihydrothieno[3,2-c]pyridinesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Apr 17, 2018·0 cites·20 claims
- 2953US2022356163A1SMALL MOLECULE INHIBITORS OF Id PROTEINSMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 3051US10975051B2Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Apr 13, 2021·0 cites·25 claims
- 3151US2023346988A1Systems for in vivo monitoring of immune cells in patients undergoing cellular immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3250US2023256121A1Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3350US2023348853A1C825 expressing immune cells and diagnostic uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3449US2022257601A1Inhibitors of prc1 for treatment of cancerUNIV TEXAS·Filed 2020·Application pending·0 cites
- 3548US2003194409A1Conjugate heat shock protein-binding peptidesFiled 2002·Application pending·0 cites
- 3647US11098021B2Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Aug 24, 2021·0 cites·25 claims
- 3746US2003134787A1Conjugate heat shock protein-binding peptidesFiled 2002·Application pending·0 cites
- 3846US2003166530A1Conjugate heat shock protein-binding peptidesFiled 2002·Application pending·0 cites
- 3944US9546146B2Migrastatins and uses thereofSLOAN-KETTERING INST FOR CANCER RES·Filed 2016·Granted Jan 17, 2017·0 cites·41 claims
- 4044US2021188787A1Dota compounds and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ouathek Ouerfelli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →